ION582

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman SyndromeNCT05127226IONSPhase 1, Phase 2Active not recruiting2032-03Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.